These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28277090)

  • 1. Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore.
    Lau YF; Tang LH; Chien Lye D; Ooi EE; Leo YS
    Hum Vaccin Immunother; 2017 Mar; 13(3):551-560. PubMed ID: 28277090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.
    Rinaldi S; Zangari P; Cotugno N; Manno EC; Brolatti N; Castrucci MR; Donatelli I; Rossi P; Palma P; Cagigi A
    Vaccine; 2014 Feb; 32(6):657-63. PubMed ID: 24333344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection.
    Hakim H; Allison KJ; Van de Velde LA; Tang L; Sun Y; Flynn PM; McCullers JA
    Vaccine; 2016 Jun; 34(27):3141-3148. PubMed ID: 27129426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial.
    McKittrick N; Frank I; Jacobson JM; White CJ; Kim D; Kappes R; DiGiorgio C; Kenney T; Boyer J; Tebas P
    Ann Intern Med; 2013 Jan; 158(1):19-26. PubMed ID: 23277897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults.
    Liu Z; Pang C; Deng Y; Guo C; Li J; Li Y; Xin R; Li X; Xu C; Huang C; Lu H; Li J
    Vaccine; 2023 Jul; 41(34):4978-4985. PubMed ID: 37394372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.
    Low JG; Lee LS; Ooi EE; Ethirajulu K; Yeo P; Matter A; Connolly JE; Skibinski DA; Saudan P; Bachmann M; Hanson BJ; Lu Q; Maurer-Stroh S; Lim S; Novotny-Diermayr V
    Vaccine; 2014 Sep; 32(39):5041-8. PubMed ID: 25045806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children.
    Phongsamart W; Sirisanthana V; Wittawatmongkol O; Maleesatharn A; Sudjaritruk T; Chearskul P; Aurpibul L; Sirisanthana T; Chokephaibulkit K
    Vaccine; 2011 Nov; 29(47):8705-11. PubMed ID: 21893147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
    Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
    J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hemagglutination inhibition and microbead array assays for the measurement of influenza antibody levels in HIV-infected adults.
    Thorne A; Chowdhury F; Singer J; Keynan Y; Fowke KR; Cooper C;
    Vaccine; 2016 Jun; 34(31):3584-91. PubMed ID: 27211040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
    Belshe RB; Frey SE; Graham IL; Anderson EL; Jackson LA; Spearman P; Edupuganti S; Mulligan MJ; Rouphael N; Winokur P; Dolor RJ; Woods CW; Walter EB; Chen WH; Turley C; Edwards KM; Creech CB; Hill H; Bellamy AR;
    JAMA; 2014 Oct; 312(14):1420-8. PubMed ID: 25291578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
    Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
    Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, immunogenicity and shedding of LAIV4 in HIV-infected and uninfected children.
    Curtis D; Ning MF; Armon C; Li S; Weinberg A
    Vaccine; 2015 Sep; 33(38):4790-7. PubMed ID: 26241950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard-Dose Intradermal Influenza Vaccine Elicits Cellular Immune Responses Similar to Those of Intramuscular Vaccine in Men With and Those Without HIV Infection.
    Amoah S; Mishina M; Praphasiri P; Cao W; Kim JH; Liepkalns JS; Guo Z; Carney PJ; Chang JC; Fernandez S; Garg S; Beacham L; Holtz TH; Curlin ME; Dawood F; Olsen SJ; Gangappa S; Stevens J; Sambhara S
    J Infect Dis; 2019 Jul; 220(5):743-751. PubMed ID: 31045222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to the influenza vaccine in healthcare workers.
    Sacadura-Leite E; Sousa-Uva A; Rebelo-de-Andrade H
    Vaccine; 2012 Jan; 30(2):436-41. PubMed ID: 22064268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to trivalent influenza vaccine in Iranian adults infected with human immunodeficiency virus.
    Rasoolinejad M; Jafari S; Montazeri M; Mohseni M; Foroughi M; Moradmand Badie B; Saatian M; Marashi SM; Mokhtari Azad T
    Acta Med Iran; 2013 Apr; 51(3):148-52. PubMed ID: 23605597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
    Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
    Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
    Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
    AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.